EPIVAC

Effectiveness of pneumococcal and influenza vaccines

The EPIVAC group was formed within the primary health services of Tarragona-Valls and comprises a multidisciplinary group of researchers and primary health care professionals. It is a well consolidated group accredited by IDIAP Jordi Gol and by AGAUR (agency for the management of university and research grants of the Catalan Generalitat). Basically the group carries out population-based clinical an epidemiological research into infectious respiratory diseases which are preventable by vaccination.

The group participates in the following projects

PI: Aragón Pérez, María. vACCine covid-19 monitoring readinESS (ACCESS). Funding: UMC Utrecht (University Medical Center Utrecht). Duration: 2020 - 2022

PI: Vila Corcoles, Angel. Incidencia y caracterización de perfiles de bajo/alto riesgo de complicación en personas >60 años con COVID19. Funding: Instituto de Salud Carlos III. Duration: 2020 - 2021

PI: Gens Barberà, Montserrat. Efectividad de la implementación de distintas herramientas de Seguridad del Paciente para definir un nuevo mapa de riesgo en Atención Primaria. Funding: Instituto de Salud Carlos III. Duration: 2018 - 2021

PI: Moral Parras, Pedro. Portadores intestinales comunitarios de Enterobacterias productoras de lactamasas de espectro extendido y carbapenemasas plasmídicas en las Regiones Sanitarias Terres de l'Ebre, Camp de Tarragona y Girona. Funding: Fundacio Doctor Ferran. Duration: 2019 - 2020

PI: Hernandez Vidal, Nuria. Mapa de riscos en Atenció Domiciliària. Funding: IDIAP Jordi Gol. Duration: 2019 - 2020

PI: Hernandez Vidal, Nuria. Monitoratge de la cultura de seguretat en Atenció Primària mitjançant la validació de la versió catalana del qüestionari MOSPSC (Medical Office Survey on Patient Safety Culture). Funding: ICS - Institut Català de la Salut. Duration: 2018 - 2020

PI: Vila Corcoles, Angel. Efectividad clínica de la vacuna antineumocócica conjugada 13-valente versus vacuna polisacárida 23-valente en los adultos mayores de 50 años: estudio de cohortes de base poblacional. Funding: Instituto de Salud Carlos III. Duration: 2016 - 2020

The group participates in the following publications

Vila A, Ochoa O, Torrente C, Vila A, Satué EM, Hospital I, de Diego C, Gómez FF, Basora J. Evaluación de la incidencia y perfil de riesgo de Covid-19 según comorbilidad previa en adultos ?50 años del área de Tarragona. Rev Esp Salud Publica. 2020;94:1-15. PMID:3258837. IF: 0,746.

Vila-Corcoles A, Hospital I, Ochoa-Gondar O, Satue E, de Diego C, Vila-Rovira A, Gómez-Bertomeu F, Raga X, Aragón M. Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016. Vaccine. 2020 Jan; 38(5):1170-1180. doi:10.1016/j.vaccine.2019.11.012. Epub 2019 Nov 20. PMID:31759735. IF: 3,143.

Vila-Córcoles A, Ochoa-Gondar O, Satué-Gracia EM, Torrente-Fraga C, Gomez-Bertomeu F, Vila-Rovira A, Hospital-Guardiola I, de Diego-Cabanes C, Bejarano-Romero F, Basora-Gallisà J. Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain. BMJ Open. 2020 12; 10(12):e041577. doi:10.1136/bmjopen-2020-041577. Epub 2020 Dec 10. pmc:PMC7733229. PMID:33303459. IF: 2,496.

Vila-Córcoles Á, Ochoa-Gondar O, Torrente-Fraga C, Vila-Rovira Á, Satué-Gracia E, Hospital-Guardiola I, de Diego-Cabanes C, Gómez-Bertomeu F, Basora-Gallisà J. [Evaluation of incidence and risk profile for suffering Covid-19 infection by underlying conditions among middle-aged and older adults in Tarragona.]. Rev Esp Salud Publica. 2020 Jun; 94. Epub 2020 Jun 26. Spanish. PMID:32588837. IF: 0,746.

Vila-Corcoles A, Ochoa-Gondar O, Vila-Rovira A, Aragon M, Esteban-Julvez L, Chamorro N, Hospital I, Satue E, Blade J, de Diego C, Gomez-Bertomeu F, Raga X. Incidence and Risk of Pneumococcal Pneumonia in Adults with Distinct Underlying Medical Conditions: A Population-Based Study. Lung. 2020 06; 198(3):481-489. doi:10.1007/s00408-020-00349-y. Epub 2020 Apr 06. PMID:32253492. IF: 1,817.

Vila-Corcoles A, Satue-Gracia E, Ochoa-Gondar O, Torrente-Fraga C, Gomez-Bertomeu F, Vila-Rovira A, Hospital-Guardiola I, de Diego-Cabanes C, Bejarano-Romero F, Rovira-Veciana D, Basora-Gallisa J. Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: A population-based cohort study in Southern Catalonia, Spain. J Clin Hypertens (Greenwich). 2020 08; 22(8):1379-1388. doi:10.1111/jch.13948. Epub 2020 Jul 25. PMID:32710674. IF: 2,719.

Indicators

Indicator

2020

Researchers with PhD

19

Total number of projects in which group members have participated

7

Total number of projects in which the PI of the project has belonged to the group

2

Total Funding

143.581 €

Scientific publications in indexed journals

6

Total Impact factor

11,67

Nº of articles in Q1 journals

0

Q1 IF

 

Nº of articles in Q2 journals

3

Q2 IF

8,358

Anar a l'inici